Bypass Navigation/Skip to Content
Eyes on Diabetes - Discussing Diabetic Retinopathy

Info for Health Professionals

Relevant Eye Care Journal Articles

Frank, R. 2004, 'Diabetes Retinopathy,' New England Journal of Medicine, Vol. 350, p.p. 48 - 58.

McCarty DJ, Fu CL, Harper CA, Taylor HR, McCarty CA. Five Year Incidence of Diabetic Retinopathy in Melbourne Visual Impairment Project. Clinical and Experimental Ophthalmology. 2003 Oct: 31(5): 397-402

Tapp RJ, Shaw JE, Harper CA, de Courten MP, Balkau B, McCarty DJ, Taylor HR, Welborn TA, Zimmet PZ; AusDiab Study Group "The Prevalence of and factors associated with diabetic retinopathy in the Australian population" Diabetes Care. 2003 Jun;26(6):1731-7


Pires I. Bernardes RC. Lobo CL. Soares MA. Cunha-Vaz JG. Retinal thickness in eyes with mild nonproliferative retinopathy in patients with type 2 diabetes mellitus: comparison of measurements obtained by retinal thickness analysis and optical coherence tomography.Archives of Ophthalmology. 120(10):1301-6, 2002 Oct.

Jonas JB. Degenring R. [Intravitreal injection of crystalline triamcinolone acetonide in the treatment of diffuse diabetic macular oedema] . [German] Klinische Monatsblatter fur Augenheilkunde. 219(6):429-32, 2002 Jun.

Sato Y. Lee Z. The subclassification and long-term prognosis of preproliferative diabetic retinopathy. Japanese Journal of Ophthalmology. 46(3):323-9, 2002 May-Jun.

Fanelli A. Hadjadj S. Gallois Y. Fumeron F. Betoule D. Grandchamp B. Marre M. [Polymorphism of aldose reductase gene and susceptibility to retinopathy and nephropathy in Caucasians with type 1 diabetes]. [French] Archives des Maladies du Coeur et des Vaisseaux. 95(7-8):701-8, 2002 Jul-Aug.

Pires I. Bernardes RC. Lobo CL. Soares MA. Cunha-Vaz JG. Retinal thickness in eyes with mild nonproliferative retinopathy in patients with type 2 diabetes mellitus: comparison of measurements obtained by retinal thickness analysis and optical coherence tomography. Archives of Ophthalmology. 120(10):1301-6, 2002 Oct.

James M. Turner DA. Broadbent DM. Vora J. Harding SP. Cost effectiveness analysis of screening for sight threatening diabetic eye disease. [see comments.] [erratum appears in BMJ 2000 Aug 12;321(7258):424.]. BMJ. 320(7250):1627-31, 2000 Jun 17.

McLeod D. Diabetic tractional papillopathy: a new (and true) nosological entity? [letter; comment.]. British Journal of Ophthalmology. 83(3):257-8, 1999 Mar.

Kroll P. Wiegand W. Schmidt J. Vitreopapillary traction in proliferative diabetic vitreoretinopathy [see comments]. [see comments.]. British Journal of Ophthalmology. 83(3):261-4, 1999 Mar.

Shinoda K. Ishida S. Kawashima S. Wakabayashi T. Matsuzaki T. Takayama M. Shinmura K. Yamada M. Comparison of the levels of hepatocyte growth factor and vascular endothelial growth factor in aqueous fluid and serum with grades of retinopathy in patients with diabetes mellitus. [see comments.]. British Journal of Ophthalmology. 83(7):834-7, 1999 Jul.

Ochiai Y. Ochiai H. Higher concentration of transforming growth factor-beta in aqueous humor of glaucomatous eyes and diabetic eyes. Japanese Journal of Ophthalmology. 46(3):249-53, 2002 May-Jun.

Sato Y. Lee Z. Shimada H. Vitrectomy for diabetic cystoid macular edema. Japanese Journal of Ophthalmology. 46(3):315-22, 2002 May-Jun.

Sato Y. Lee Z. The subclassification and long-term prognosis of preproliferative diabetic retinopathy. Japanese Journal of Ophthalmology. 46(3):323-9, 2002 May-Jun.

Kemp A. [Diabetic retinopathy--a reply]. [Danish] Ugeskrift for Laeger. 164(37):4301, 2002 Sep 9.

Fanelli A. Hadjadj S. Gallois Y. Fumeron F. Betoule D. Grandchamp B. Marre M. [Polymorphism of aldose reductase gene and susceptibility to retinopathy and nephropathy in Caucasians with type 1 diabetes]. [French] Archives des Maladies du Coeur et des Vaisseaux. 95(7-8):701-8, 2002 Jul-Aug.

Pires I. Bernardes RC. Lobo CL. Soares MA. Cunha-Vaz JG. Retinal thickness in eyes with mild nonproliferative retinopathy in patients with type 2 diabetes mellitus: comparison of measurements obtained by retinal thickness analysis and optical coherence tomography. Archives of Ophthalmology. 120(10):1301-6, 2002 Oct.

Jonas JB. Degenring R. [Intravitreal injection of crystalline triamcinolone acetonide in the treatment of diffuse diabetic macular oedema]. [German] Klinische Monatsblatter fur Augenheilkunde. 219(6):429-32, 2002 Jun.

Sander B. Larsen M. Engler C. Moldow B. Lund-Andersen H. Diabetic macular oedema: the effect of photocoagulation on fluorescein transport across the blood-retinal barrier. British Journal of Ophthalmology. 86(10):1139-42, 2002 Oct.

Cook HL. Newsom RS. Mensah E. Saeed M. James D. Ffytche TJ. Entonox as an analgesic agent during panretinal photocoagulation. British Journal of Ophthalmology. 86(10):1107-8, 2002 Oct.

Local Messages

Walker EA. Zybert PA. Basch CE. What is the sensitivity and specificity of self-report for retinopathy screening? Diabetes Care. 25(5):933-4, 2002 May.

Pierzchala K. Kwiecinski J. [Blood flow in ophthalmic artery and visual evoked potentials in diabetic patients]. [Polish] Wiadomosci Lekarskie. 55(3-4):183-8, 2002.

Harada T. Harada C. Mitamura Y. Akazawa C. Ohtsuka K. Ohno S. Takeuchi S. Wada K. Neurotrophic factor receptors in epiretinal membranes after human diabetic retinopathy. Diabetes Care. 25(6):1060-5, 2002 Jun.

Sdobnikova SV. Fedorov AA. Chekmareva IA. Stoliarenko GE. Mazurina NK. [Pathological basis for clinical stages of the proliferative process in diabetic retinopathy]. [Russian] Vestnik Oftalmologii. 118(2):20-1, 2002 Mar-Apr.

Gheorghiu M. [Electrical changes in the middle retinal layer in diabetic retinopathy]. [Romanian] Oftalmologia. 53(3):61-5, 2001.

Harding S. Diabetic retinopathy. Clinical Evidence. (7):580-8, 2002 Jun.

Knudsen LL. Andersen CU. Lervang HH. Vad J. [Photographic screening for diabetic retinopathy in the county of North Jutland. The first fully digitalized telemedicine-screening clinic]. [see comments.]. [Review] [14 refs] [Danish] Ugeskrift for Laeger. 164(24):3180-4, 2002 Jun 10.

Chiarelli F. Mohn A. Angiopathy in children with diabetes. [Review] [104 refs] Minerva Pediatrica. 54(3):187-201, 2002 Jun.

Kemp A. [Consensus on ophthalmological screening in diabetes]. [letter; comment.]. [Danish] Ugeskrift for Laeger. 164(33):3872; discussion 3872-3, 2002 Aug 12.

Sjolie AK. Chaturvedi N. The retinal renin-angiotensin system: implications for therapy in diabetic retinopathy. [Review] [22 refs] Journal of Human Hypertension. 16 Suppl 3:S42-6, 2002 Aug.

Walker R. Rodgers J. Diabetic retinopathy. [Review] [16 refs] Nursing Standard. 16(45):46-52; quiz 54-5, 2002 Jul 24.

Whittington AE. The visually impaired specialty diabetes educator: seeing is believing. Diabetes Educator. 28(4):527-8, 2002 Jul-Aug.

Confos N. Frith J. Mitchell P. Training GPs to screen for diabetic retinopathy. The impact of short term intensive education, Australian Family Physician. 32(5):381-2, 384, 2003 May.

Knudsen ST. Poulsen PL. Hansen KW. Ebbehoj E. Bek T. Mogensen CE. Pulse pressure and diurnal blood pressure variation: association with micro- and macrovascular complications in type 2 diabetes. American Journal of Hypertension. 15(3):244-50, 2002 Mar.

Ellis EA. Guberski DL. Hutson B. Grant MB. Time course of NADH oxidase, inducible nitric oxide synthase and peroxynitrite in diabetic retinopathy in the BBZ/WOR rat. Nitric Oxide. 6(3):295-304, 2002 May.

Narendran V. John RK. Raghuram A. Ravindran RD. Nirmalan PK. Thulasiraj RD. Diabetic retinopathy among self reported diabetics in southern India: a population based assessment. British Journal of Ophthalmology. 86(9):1014-8, 2002 Sep.

Luz C. National campaign yields positive results for patients with diabetes. Healthplan. 43(4):50-1, 2002 Jul-Aug.

Bhavsar AR. Diabetic retinopathy. The diabetes eye exam initiative. Minnesota Medicine. 85(6):46-7, 2002 Jun.

Nakanishi T. Koyama R. Ikeda T. Shimizu A. Catalogue of soluble proteins in the human vitreous humor: comparison between diabetic retinopathy and macular hole. Journal of Chromatography B: Analytical Technologies in the Biomedical & Life Sciences. 776(1):89-100, 2002 Aug 25.

Kannabiran C. Panicker SG. Of genes and disease. [letter; comment.]. Indian Journal of Ophthalmology. 50(1):2-3, 2002 Mar.

Radha V. Rema M. Mohan V. Genes and diabetic retinopathy. [see comments.]. [Review] [50 refs] Indian Journal of Ophthalmology. 50(1):5-11, 2002 Mar.

Pandit RJ. Taylor R. Quality assurance in screening for sight-threatening diabetic retinopathy. Diabetic Medicine. 19(4):285-91, 2002 Apr.

Kamiuchi K. Hasegawa G. Obayashi H. Kitamura A. Ishii M. Yano M. Kanatsuna T. Yoshikawa T. Nakamura N. Intercellular adhesion molecule-1 (ICAM-1) polymorphism is associated with diabetic retinopathy in Type 2 diabetes mellitus. Diabetic Medicine. 19(5):371-6, 2002 May.

Kumaramanickavel G. Sripriya S. Vellanki RN. Upadyay NK. Badrinath SS. Rajendran V. Sukumar B. Ramprasad VL. Sharma T. Inducible nitric oxide synthase gene and diabetic retinopathy in Asian Indian patients. Clinical Genetics. 61(5):344-8, 2002 May.

Enge M. Bjarnegard M. Gerhardt H. Gustafsson E. Kalen M. Asker N. Hammes HP. Shani M. Fassler R. Betsholtz C. Endothelium-specific platelet-derived growth factor-B ablation mimics diabetic retinopathy. EMBO Journal. 21(16):4307-16, 2002 Aug 15.

Helbig H. [Diabetic tractional retinal detachment]. [German] Klinische Monatsblatter fur Augenheilkunde. 219(4):186-90, 2002 Apr.

Movaffaghy A. Chamot SR. Dosso A. Pournaras CJ. Sommerhalder JR. Riva CE. Effect of isometric exercise on choroidal blood flow in type I diabetic patients. Klinische Monatsblatter fur Augenheilkunde. 219(4):299-301, 2002 Apr.

Matsumoto Y. Takahashi M. Ogata M. Relationship between glycoxidation and cytokines in the vitreous of eyes with diabetic retinopathy. Japanese Journal of Ophthalmology. 46(4):406-12, 2002 Jul-Aug.

Amino K. Tanihara H. Vitrectomy combined with phacoemulsification and intraocular lens implantation for diabetic macular edema. Japanese Journal of Ophthalmology. 46(4):455-9, 2002 Jul-Aug.

Boehm BO. Lustig RH. Use of somatostatin receptor ligands in obesity and diabetic complications. [Review] [104 refs] Best Practice & Research in Clinical Gastroenterology. 16(3):493-509, 2002 Jun.

Knudsen LL. Andersen CU. Lervang HH. Vad J. [Photographic screening for diabetic retinopathy in the county of North Jutland. The first fully digitalized [Review] [14 refs] [Danish] Ugeskrift for Laeger. 164(24):3180-4, 2002 Jun 10.

Lee do H. Seo Y. Joo CK. Progressive opacification of hydrophilic acrylic intraocular lenses in diabetic patients. Journal of Cataract & Refractive Surgery. 28(7):1271-5, 2002 Jul.

Nishiwaki H. Shahidi M. Vitale S. Alexander J. Asran S. Mori M. Blair NP. Zeimer R. Relation between retinal thickening and clinically visible fundus pathologies in mild nonproliferative diabetic retinopathy. Ophthalmic Surgery & Lasers. 33(2):127-34, 2002 Mar-Apr.

Li Q. Puro DG. Diabetes-induced dysfunction of the glutamate transporter in retinal Müller cells. Investigative Ophthalmology & Visual Science. 43(9):3109-16, 2002 Sep.

Chiarelli F. Mohn A. Tumini S. Trotta D. Verrotti A. Screening for vascular complications in children and adolescents with type 1 diabetes mellitus. Hormone Research. 57 Suppl 1:113-6, 2002.

Maberley DA. King W. Cruess AF. Koushik A. Risk factors for diabetic retinopathy in the Cree of James Bay. Ophthalmic Epidemiology. 9(3):153-67, 2002 Jul.

Maberley D. Cruess AF. Barile G. Slakter J. Digital photographic screening for diabetic retinopathy in the James Bay Cree. Ophthalmic Epidemiology. 9(3):169-78, 2002 Jul.

Lopez IM. Diez A. Velilla S. Rueda A. Alvarez A. Pastor CJ. Prevalence of diabetic retinopathy and eye care in a rural area of Spain. Ophthalmic Epidemiology. 9(3):205-14, 2002 Jul.

Ogata N. Nishikawa M. Nishimura T. Mitsuma Y. Matsumura M. Unbalanced vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in diabetic retinopathy. American Journal of Ophthalmology. 134(3):348-53, 2002 Sep.

Simo R. Lecube A. Segura RM. Garcia Arumi J. Hernandez C. Free insulin growth factor-I and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy. American Journal of Ophthalmology. 134(3):376-82, 2002 Sep.

West SK. Munoz B. Klein R. Broman AT. Sanchez R. Rodriguez J. Snyder R. Risk factors for Type II diabetes and diabetic retinopathy in a mexican-american population: Proyecto VER. American Journal of Ophthalmology. 134(3):390-8, 2002 Sep.

Younis N. Diabetic control and retinopathy. British Journal of General Practice. 52(481):676, 2002 Aug.

Stitt A. Gardiner TA. Anderson NL. Canning P. Frizzell N. Duffy N. Boyle C. Januszewski AS. Chachich M. Baynes JW. Thorpe SR. The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes. Diabetes. 51(9):2826-32, 2002 Sep.

Danny Y. Lin, MD, Mark S. Blumenkranz, MD, Rosemary J. Brothers, and DavidM. Grosvenor MPH, For the Digital Diabetic Screening Group*The Sensitivity and Specificity of Single-field Nonmydriatic Monochromatic Digital Fundus Photography With Remote Image Interpretation for Diabetic Retinopathy Screening: A Comparison with Ophthalmoscopy and Standardized Mydriatic Colour Photography.American Journal of Ophthalmology Vol. 134, No. 2 p204-213

Ono T. Kobayashi J. Sasako Y. Bando K. Tagusari O. Niwaya K. Imanaka H. Nakatani T. Kitamura S. The impact of diabetic retinopathy on long-term outcome following coronary artery bypass graft surgery. Journal of the American College of Cardiology. 40(3):428-36, 2002 Aug 7.

Al-Bdour MD. Al-Till MI. Abu-Khader IB. Causes of blindness among adult Jordanians: a hospital-based study. European Journal of Ophthalmology. 12(1):5-10, 2002 Jan-Feb.

Ambulatory blood pressure monitoring: is it necessary for the routine assessment of hypertension in people with diabetes? M. W. J.Strachan, K.Gough, J. A.McKnight, P. L.Padfield Diabetic Medicine; Volume 19, Issue 9, Page 787

The evaluation of screening policies for diabetic retinopathy using simulation R.Davies, P.Roderick, C.Canning, S.Brailsford Diabetic Medicine; Volume 19, Issue 9, Page 762

Evaluation of a district-wide screening programme for diabetic retinopathy utilizing trained optometrists using slit-lamp and Volk lenses S. A.Hulme, A.Tin-U, K. J.Hardy, P. W.Joyce Diabetic Medicine; Volume 19, Issue 9, Page 741

Editorial IGT and IFG. Time for revision? K.Borch-Johnsen Diabetic Medicine; Volume 19, Issue 9, Page 707  

Shestakova MV. Kochemasova TV. Gorelysheva VA. Osipova TV. Polosukhina EP. Baryshnikov AIu. Dedov II. [The role of adhesion molecules (ICAM-1 and E-selectin) in development of diabetic microangiopathies]. [Russian] Terapevticheskii Arkhiv. 74(6):24-7, 2002.

Lin DY. Blumenkranz MS. Brothers RJ. Grosvenor DM. The sensitivity and specificity of single-field nonmydriatic monochromatic digital fundus photography with remote image interpretation for diabetic retinopathy screening: a comparison with ophthalmoscopy and standardized mydriatic color photography. [see comments.]. American Journal of Ophthalmology. 134(2):204-13, 2002 Aug.

Otani T. Kishi S. A controlled study of vitrectomy for diabetic macular edema. American Journal of Ophthalmology. 134(2):214-9, 2002 Aug.

Klein R. Klein BE. Screening for diabetic retinopathy, revisited. [letter; comment.]. American Journal of Ophthalmology. 134(2):261-3, 2002 Aug.

Beranek M. Kankova K. Benes P. Izakovicova-Holla L. Znojil V. Hajek D. Vlkova E. Vacha J. Polymorphism R25P in the gene encoding transforming growth factor-beta (TGF-beta1) is a newly identified risk factor for proliferative diabetic retinopathy. American Journal of Medical Genetics. 109(4):278-83, 2002 May 15.

Mackay CJ. Tomographic assessment of vitreous surgery for diabetic macular edema. [letter; comment.]. American Journal of Ophthalmology. 133(1):166, 2002 Jan.

Guo Q. Lu J. Pan C. [The abnormal reaction to post methionine loading test in type diabetes with or without retinopathy]. [Chinese] Chung-Hua i Hsueh Tsa Chih [Chinese Medical Journal]. 82(11):725-8, 2002 Jun 10.

Noma H. Funatsu H. Yamashita H. Kitano S. Mishima HK. Hori S. Regulation of angiogenesis in diabetic retinopathy: possible balance between vascular endothelial growth factor and endostatin. Archives of Ophthalmology. 120(8):1075-80, 2002 Aug.

Li Q. Zemel E. Miller B. Perlman I. Early retinal damage in experimental diabetes: electroretinographical and morphological observations. Experimental Eye Research. 74(5):615-25, 2002 May.

Taverna MJ. Sola A. Guyot-Argenton C. Pacher N. Bruzzo F. Slama G. Reach G. Selam JL. Taq I polymorphism of the vitamin D receptor and risk of severe diabetic retinopathy. Diabetologia. 45(3):436-42, 2002 Mar.

Taverna MJ. Sola A. Guyot-Argenton C. Pacher N. Bruzzo F. Chevalier A. Slama G. Reach G. Selam JL. eNOS4 polymorphism of the endothelial nitric oxide synthase predicts risk for severe diabetic retinopathy. Diabetic Medicine. 19(3):240-5, 2002 Mar.

Noma H. Funatsu H. Yamashita H. Kitano S. Mishima HK. Hori S. Regulation of angiogenesis in diabetic retinopathy: possible balance between vascular endothelial growth factor and endostatin. Archives of Ophthalmology. 120(8):1075-80, 2002 Aug.

Li Q. Zemel E. Miller B. Perlman I. Early retinal damage in experimental diabetes: electroretinographical and morphological observations. Experimental Eye Research. 74(5):615-25, 2002 May.

Taverna MJ. Sola A. Guyot-Argenton C. Pacher N. Bruzzo F. Slama G. Reach G. Selam JL. Taq I polymorphism of the vitamin D receptor and risk of severe diabetic retinopathy. Diabetologia. 45(3):436-42, 2002 Mar.

Taverna MJ. Sola A. Guyot-Argenton C. Pacher N. Bruzzo F. Chevalier A. Slama G. Reach G. Selam JL. eNOS4 polymorphism of the endothelial nitric oxide synthase predicts risk for severe diabetic retinopathy. Diabetic Medicine. 19(3):240-5, 2002 Mar.

Kowluru RA. Diabetes-induced elevations in retinal oxidative stress, protein kinase C and nitric oxide are interrelated. Acta Diabetologica. 38(4):179-85, 2001 Dec.

Skarf B. Retinal nerve fibre layer loss in diabetes mellitus without retinopathy. [letter; comment.]. British Journal of Ophthalmology. 86(7):709, 2002 Jul.

Castellon R. Caballero S. Hamdi HK. Atilano SR. Aoki AM. Tarnuzzer RW. Kenney MC. Grant MB. Ljubimov AV. Effects of tenascin-C on normal and diabetic retinal endothelial cells in culture. Investigative Ophthalmology & Visual Science. 43(8):2758-66, 2002 Aug.

Kawai S. Nakajima T. Hokari S. Komoda T. Kawai K. Apolipoprotein A-I concentration in tears in diabetic retinopathy. Annals of Clinical Biochemistry. 39(Pt 1):56-61, 2002 Jan.

Yu M. Zhang X. Zhong X. Yu Q. Jiang F. Ma J. Wu D. Multifocal electroretinograms in the early stages of diabetic retinopathy. Chinese Medical Journal. 115(4):563-6, 2002 Apr.

Freudenstein U. Verne J. A national screening programme for diabetic retinopathy. Needs to learn the lessons of existing screening programmes. [see comments.]. BMJ. 323(7303):4-5, 2001 Jul 7.

Prasad S. Swindlehurst H. Cleaqrkin LG. National screening programme for diabetic retinopathy. Screening by optometrists is better than screening by fundus photography. [see comments.]. BMJ. 323(7319):998-9, 2001 Oct 27.

Malone JI. Morrison AD. Pavan PR. Cuthbertson DD. Diabetic Control and Complications Trial. Prevalence and significance of retinopathy in subjects with type 1 diabetes of less than 5 years' duration screened for the diabetes control and complications trial. [see comments.]. Diabetes Care. 24(3):522-6, 2001 Mar.

Anonymous. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. [erratum appears in N Engl J Med 2000 May 4;342(18):1376.]. New England Journal of Medicine. 342(6):381-9, 2000 Feb 10.

Newsom RS. Sinthanayothin C. Boyce J. Casswell AG. Williamson TH. Clinical evaluation of 'local contrast enhancement' for oral fluorescein angiograms. Eye. 14 ( Pt 3A):318-23, 2000 Jun.

Bresnick GH. Mukamel DB. Dickinson JC. Cole DR. A screening approach to the surveillance of patients with diabetes for the presence of vision-threatening retinopathy. [see comments.]. Ophthalmology. 107(1):19-24, 2000 Jan.

Vander JF. Ho AC. McNamara JA. Regillo CD. Brown GC. Benson WE. Tasman W. Diabetes and retinopathy. [letter; comment.]. Ophthalmology. 107(12):2120-2, 2000 Dec.

Gaudio AR. Diabetes and retinopathy. [letter; comment.]. Ophthalmology. 107(12):2122-3, 2000 Dec.

McLeod D. Entry site neovascularisation after diabetic vitrectomy. [see comments.]. British Journal of Ophthalmology. 84(8):810-1, 2000 Aug.

West JF. Gregor ZJ. Fibrovascular ingrowth and recurrent haemorrhage following diabetic vitrectomy. [see comments.]. British Journal of Ophthalmology. 84(8):822-5, 2000 Aug.

Kreiger A. Sclerotomy complications following pars plana vitrectomy. [letter; comment.]. British Journal of Ophthalmology. 85(1):121-2, 2001 Jan.

Grant MB. Mames RN. Fitzgerald C. Hazariwala KM. Cooper-DeHoff R. Caballero S. Estes KS. The efficacy of octreotide in the therapy of severe nonproliferative and early proliferative diabetic retinopathy: a randomized controlled study.[see comments.]. Diabetes Care. 23(4):504-9, 2000 Apr.

Gehrs KM. Efficacy of octreotide in the therapy of severe nonproliferative and early proliferative diabetic retinopathy: a randomized controlled study.Response to Grant et al. [letter; comment.]. Diabetes Care. 24(1):182-3, 2001 Jan.

Engelgau MM. Thompson TJ. Herman WH. Boyle JP. Aubert RE. Kenny SJ. Badran A. Sous ES. Ali MA. Comparison of fasting and 2-hour glucose and HbA1c levels for diagnosing diabetes. Diagnostic criteria and performance revisited. [see comments.]. Diabetes Care. 20(5):785-91, 1997 May.

Maar N. Tittl M. Stur M. Zajic B. Reitner A. A new colour vision arrangement test to detect functional changes in diabetic macular oedema. [see comments.]. British Journal of Ophthalmology. 85(1):47-51, 2001 Jan.

Tong L. Carkeet A. A new colour vision arrangement test to detect functional changes in diabetic macular oedema. [letter; comment.]. British Journal of Ophthalmology. 85(8):1013-4, 2001 Aug.

Vijan S. Hofer TP. Hayward RA. Cost-utility analysis of screening intervals for diabetic retinopathy in patients with type 2 diabetes mellitus. [see comments.] JAMA. 283(7):889-96, 2000 Feb 16.

Moss SE. Klein R. Klein BE. The 14-year incidence of lower-extremity amputations in a diabetic population. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. [see comments.]. Diabetes Care. 22(6):951-9, 1999 Jun.

Lanzetta P. Malara C. Cotherapy with recombinant human IGF-I and insulin improves glycemic control in type 1 diabetes. [letter; comment.]. Diabetes Care. 23(3):436-7, 2000 Mar.

Cahill M. Wallace D. Travers S. Lipinski H. Aldington S. Costigan C. Mooney D. Detection and prevalence of early diabetic retinopathy in juvenile diabetics with diabetes for 10 years or more. [see comments.]. Eye. 14(Pt 6):847-50, 2000 Dec.

Kaiser PK. Riemann CD. Sears JE. Lewis H. Macular traction detachment and diabetic macular edema associated with posterior hyaloidal traction. [see comments.]. American Journal of Ophthalmology. 131(1):44-9, 2001 Jan.

Massin P. Haouchine B. Gaudric A. Macular traction detachment and diabetic edema associated with posterior hyaloidal traction. [letter; comment.]. American Journal of Ophthalmology. 132(4):599-600, 2001 Oct.

Janghorbani M. Jones RB. Murray KJ. Allison SP. Incidence of and risk factors for diabetic retinopathy in diabetic clinic attenders. Ophthalmic Epidemiology. (5):309-25, 2001 Dec.

Davies N. Clinical detection of diabetic retinopathy in white and green light. [letter; comment.]. [Review] [5 refs] Eye. 15(Pt 5):688-90, 2001 Oct.

Tong L. Vernon SA. Passing the DVLA field regulations following bilateral macular photocoagulation in diabetics. [see comments.]. Eye. 14 ( Pt 1):35-8, 2000 Feb.

Yu M. Zhang X. Zhong X. Yu Q. Jiang F. Ma J. Wu D. Multifocal electroretinograms in the early stages of diabetic retinopathy. Chinese Medical Journal. 115(4):563-6, 2002 Apr.

Kawai S. Nakajima T. Hokari S. Komoda T. Kawai K. Apolipoprotein A-I concentration in tears in diabetic retinopathy. Annals of Clinical Biochemistry. 39(Pt 1):56-61, 2002 Jan.

Castellon R. Caballero S. Hamdi HK. Atilano SR. Aoki AM. Tarnuzzer RW. Kenney MC. Grant MB. Ljubimov AV. Effects of tenascin-C on normal and diabetic retinal endothelial cells in culture. Investigative Ophthalmology & Visual Science. 43(8):2758-66, 2002 Aug.

Skarf B. Retinal nerve fibre layer loss in diabetes mellitus without retinopathy. [letter; comment.]. British Journal of Ophthalmology. 86(7):709, 2002 Jul.

Kowluru RA. Diabetes-induced elevations in retinal oxidative stress, protein kinase C and nitric oxide are interrelated. Acta Diabetologica. 38(4):179-85, 2001 Dec.

Dorchy H. Claes C. Verougstraete C. Risk factors of developing proliferative retinopathy in type 1 diabetic patients : role of BMI. Diabetes Care. 25(4):798-9, 2002 Apr.

Chavakis E. Riecke B. Lin J. Linn T. Bretzel RG. Preissner KT. Brownlee M. Hammes HP. Kinetics of integrin expression in the mouse model of proliferative retinopathy and success of secondary intervention with cyclic RGD peptides. Diabetologia. 45(2):262-7, 2002 Feb.

Hogeboom van Buggenum IM. Polak BC. Reichert-Thoen JW. de Vries-Knoppert WA.van Hinsbergh VW. Tangelder GJ. Angiotensin converting enzyme inhibiting therapy is associated with lower vitreous vascular endothelial growth factor concentrations in patients with proliferative diabetic retinopathy. Diabetologia. 45(2):203-9, 2002 Feb.

Broughton R. National screening programme for diabetic retinopathy. Staff are already available to do this job. [letter; comment.]. BMJ. 323(7319):999, 2001 Oct 27.

Kaul CL. Ramarao P. The role of aldose reductase inhibitors in diabetic complications: recent trends. [Review] [139 refs] Methods & Findings in Experimental & Clinical Pharmacology. 23(8):465-75, 2001 Oct.

Shirshikov IuK. [Acoustic studies in proliferative diabetic retinopathy]. [Russian]Source Vestnik Oftalmologii. 117(6):23-5, 2001 Nov-Dec.

Klein R. Sharrett AR. Klein BE. Moss SE. Folsom AR. Wong TY. Brancati FL. Hubbard LD. Couper D. ARIC Group. The association of atherosclerosis, vascular risk factors, and retinopathy in adults with diabetes : the atherosclerosis risk in communities study. Ophthalmology. 109(7):1225-34, 2002 Jul.

Hesse L. Heller G. Kraushaar N. Wesp A. Schroeder B. Kroll P. [The predictive value of a classification for proliferative diabetic vitreoretinopathy]. [German]Klinische Monatsblatter fur Augenheilkunde. 219(1-2):46-9, 2002 Jan-Feb.

Schroder A. Meinrenken J. Gockeln R. Erb C. [Positive influence of color experience on result of color-arrangement-test Roth 28-hue (E) desaturated - a clinical study on 44 patients]. [German] Klinische Monatsblatter fur Augenheilkunde. 219(1-2):33-6, 2002 Jan-Feb.

Verma L. Prakash G. Tewari HK. Diabetic retinopathy: time for action. No complacency please!. Bulletin of the World Health Organization. 80(5):419, 2002.

Drasdo N. Chiti Z. Owens DR. North RV. Effect of darkness on inner retinal hypoxia in diabetes. Lancet. 359(9325):2251-3, 2002 Jun 29.

Zeimer R. Zou S. Meeder T. Quinn K. Vitale S. A fundus camera dedicated to the screening of diabetic retinopathy in the primary-care physician's office. [erratum appears in Invest Ophthalmol Vis Sci 2002 Jul;43(7):2066.]. Investigative Ophthalmology & Visual Science. 43(5):1581-7, 2002 May.

Skopinski P. Sommer E. Borowska A. Hevelke A. Rogala E. Skopinska-Rozewska E. Angiotensin-converting enzyme activity and angiomodulatory effects of sera in patients with diabetic retinopathy. International Journal of Clinical Pharmacology Research. 21(2):73-8, 2001.

Raman V. Campbell F. Holland P. Chapman T. Dabbs T. Bodansky HJ. O'Neill DP. Retinopathy screening in children and adolescents with diabetes. Annals of the New York Academy of Sciences. 958:387-9, 2002 Apr.

Hoerle S. Poestgens H. Schmidt J. Kroll P. Effect of pars plana vitrectomy for proliferative diabetic vitreoretinopathy on preexisting diabetic maculopathy. Graefes Archive for Clinical & Experimental Ophthalmology. 240(3):197-201, 2002 Mar.

Ghoraba H. Types of macular holes encountered during diabetic vitrectomy. Retina. 22(2):176-82, 2002 Apr.

Maberley DA. Koushik A. Cruess AF. Factors associated with missed eye examinations in a cohort with diabetes. Canadian Journal of Public Health. Revue Canadienne de Sante Publique. 93(3):229-32, 2002 May-Jun.

Giusti C. Gargiulo P.  [Diabetic retinopathy: medical-legal implications and statisticalassessment of 341 type 1 and 2 diabetic patients]. [Italian] Clinica Terapeutica.  152(3):159-64, 2001 May-Jun.

Mori K. Gehlbach P.  Ando A.  Dyer G.  Lipinsky E. Chaudhry AG.  Hackett  SF. Campochiaro PA. Retina-specific expression of PDGF-B versus PDGF-A: vascular versus nonvascular proliferative retinopathy. Investigative Ophthalmology & Visual Science.  43(6):2001-6, 2002 Jun.

Kador PF. Takahashi Y. Akagi Y.  Neuenschwander H.  Greentree W.   Lackner P. Blessing K.  Wyman M. Effect of galactose diet removal on the progression of retinal vessel changes in galactose-fed dogs. Investigative Ophthalmology & Visual Science.43(6):1916-21, 2002 Jun.

Gribomont AC.[Can vitrectomy without use of microscissors improve results of surgery for proliferative diabetic retinopathy?]. [French] Bulletin de la Societe Belge d Ophtalmologie.(283):61-5, 2002.

Sverak J. Rencova E. Kvasnicka J.  Peregrin J.[The photopic ERG response in diabetes mellitus]. [Czech]Ceska a Slovenska Oftalmologie.  58(2):71-4, 2002 Apr.

Zarebska A. Czerny K. Bakiera K.  Cichacz-Kwiatkowska B.  Lis-Sochocka  M. KiS G. Wojtowicz Z. Histological changes in the retina in experimental alloxan-induced diabetes in rabbits. Annales Universitatis Mariae Curie-Sklodowska - Sectio d - Medicina. 56:81-4, 2001.

Lima-Gomez V. Rojas-Dosal JA. Leon-Rivera N. [Choroid fundus as protective factor in the development of diabetic retinopathy]. [Spanish] Gaceta Medica de Mexico. 137(5):413-8, 2001 Sep-Oct.

Zarebska A.  Lancut M  Bakiera K.  Matejko E.Czerny K. KiS G. Wojtowicz Z. Ultrastructural changes in the receptor parts of retinal rods in experimental alloxan-induced diabetes in rabbits. Annales Universitatis Mariae Curie-Sklodowska - Sectio d - Medicina. 56:77-80, 2001.

Pantoflinski J. Kieltyka A.  Szybinski Z.[Visual disability due to diabetes in Cracow voivodeship]. [Polish] Polskie Archiwum Medycyny Wewnetrznej.  106(3):847-51, 2001 Sep.

Bandurska-Stankiewicz E. Kolakowska H. Zbikowska E.[Visual disability incidence among diabetes patients in Olsztyn province in the years 1990-1999]. [Polish] Polskie Archiwum Medycyny Wewnetrznej. 106(3):839-45, 2001 Sep.

Jochmann C. Hammes HP.[Epidemiology, pathogenesis and therapy of diabetic retinopathy and maculopathy]. [German] Zeitschrift fur Arztliche Fortbildung und Qualitatssicherung. 96(3):167-74, 2002 Mar.

Massin P. Marre M.[Fundus photography for the screening for diabetic retinopathy]. [French] Diabetes & Metabolism.  28(2):151-5, 2002 Apr.

Bouhanick B. Bellanne-Chantelot C.  Salle A.  Guilloteau G.  Ebran JM. Proliferative retinopathy in patients with type 1 diabetes of less than 5 years' duration.  Diabetes & Metabolism.  28(2):141-4, 2002 Apr.

Yang G. Lu J.  Pan C. [The impact of plasma homocysteine level on development of retinopathy in type 2 diabetes mellitus]. [Chinese] Chung-Hua Nei Ko Tsa Chih Chinese Journal of Internal Medicine. 41(1):34-8, 2002 Jan.

Razvi FM.Kritzinger EE. Tsaloumas MD.  Ryder RE. Use of oral fluorescein angiography in the diagnosis of macular oedema within a diabetic retinopathy screening programme.Diabetic Medicine.18(12):1003-6, 2001 Dec.

Frank RN. Potential new medical therapies for diabetic retinopathy: protein kinase C inhibitors. [Review] [45 refs] American Journal of Ophthalmology. 133(5):693-8, 2002 May.

Squirrell D. Bhola R. Bush J. Winder S. Talbot JF. A prospective, case controlled study of the natural history of diabetic retinopathy and maculopathy after uncomplicated phacoemulsification cataract surgery in patients with type 2 diabetes. British Journal of Ophthalmology. 86(5):565-71, 2002 May.

Asensio Sanchez VM. Perez Flandez FJ. Carlos Bejarano J. Fernandez Concellon L. [Vitreous hemorrhage after vitrectomy in diabetic retinopathy and tissue plasminogen activator]. [Spanish] Archivos de la Sociedad Espanola de Oftalmologia. 77(1):7-12, 2002 Jan.

Herd H. Aldington SJ. Screening for diabetic retinopathy: developing a standardized photographic protocol for St. John's Hospital. Journal of Audiovisual Media in Medicine. 25(1):28-33, 2002 Mar.

Gastaud P. Schauer P. Rouhette H. Folquet P. Negre F. [Surgical indications for diabetic maculopathy]. [French] Journal Francais d Ophtalmologie. 25(2):166-77, 2002 Feb.

Vaphiades MS.The disk edema dilemma. Survey of Ophthalmology. 47(2):183-8, 2002 Mar-Apr.

Sakamoto T. Fujisawa K. Kinukawa N. Ishibashi T. Inomata H. Re-worsening factor after successful vitrectomy for diabetic retinopathy: optic disc fibrovascular roliferation and macular disease. Ophthalmologica. 216(2):101-7, 2002 Mar-Apr.

Zeimer R. Zou S. Meeder T. Quinn K. Vitale S. A fundus camera dedicated to the screening of diabetic retinopathy in the primary-care physician's office . Investigative Ophthalmology & Visual Science. 43(5):1581-7, 2002 May.

Sanchez-Tocino H. Alvarez-Vidal A. Maldonado MJ. Moreno-Montanes J. Garcia-Layana A. Retinal thickness study with optical coherence tomography in patients with diabetes. Investigative Ophthalmology & Visual Science. 43(5):1588-94, 2002 May.

Rosenbaum JT.Sugar creates a sticky business: round up the usual suspects. [letter; comment.]. American Journal of Pathology. 160(5):1547-50, 2002 May.

Joussen AM. Poulaki V. Tsujikawa A. Qin W. Qaum T. Xu Q. Moromizato Y. Bursell SE. Wiegand SJ. Rudge J. Ioffe E. Yancopoulos GD. Adamis AP. Suppression of diabetic retinopathy with angiopoietin-1. American Journal of Pathology. 160(5):1683-93, 2002 May.

Liu DP. Molyneaux L.  Chua E.  Wang YZ.  Wu CR.  Jing H.  Hu LN.  Liu YJ.  Xu ZR. Yue DK.  Retinopathy in a Chinese population with type 2 diabetes: factors affecting the presence of this complication at diagnosis of diabetes. Diabetes Research & Clinical Practice.  56(2):125-31, 2002 May.

Frank RN. Potential new medical therapies for diabetic retinopathy: protein kinase C inhibitors. [Review] [45 refs] American Journal of Ophthalmology. 133(5):693-8, 2002 May.

Flesner P. Sander B. Henning V. Parving HH. Dornonville de la Cour M. Lund-Andersen H. Cataract surgery on diabetic patients . A prospective evaluation of risk factors and complications. Acta Ophthalmologica Scandinavica. 80(1):19-24, 2002 Feb.

Bek T. A clinicopathological study of venous loops and reduplications in diabetic retinopathy. Acta Ophthalmologica Scandinavica.  80(1):69-75, 2002 Feb.

Adamis AP. Is diabetic retinopathy an inflammatory disease? British Journal of Ophthalmology. 86(4):363-5, 2002 Apr.

Klein R. Klein BE. Blood pressure control and diabetic retinopathy. British Journal of Ophthalmology. 86(4):365-7, 2002 Ap r.

El-Asrar AM. Al-Rubeaan KA. Al-Amro SA. Moharram OA. Kangave D. Retinopathy as a predictor of other diabetic complications. International Ophthalmology. 24(1):1-11, 2001.

Awata T. Inoue K. Kurihara S. Ohkubo T. Watanabe M. Inukai K. Inoue I. Katayama S. A common polymorphism in the 5\'-untranslat ed region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes. 51(5):1635-9, 2002 May.

Sen K. Misra A. Kumar A. Pandey RM. Simvastatin retards progression of retinopathy in diabetic patients with hypercholesterole mia. Diabetes Research & Clinical Practice. 56(1):1-11, 2002 Apr.

Bamroongsuk P. Yi Q. Harper CA. McCarty D. Delivery of photocoagulation treatment for diabetic retinopathy at a large Australi an ophthalmic hospital: comparisons with national clinical practice guidelines. Clinical & Experimental Ophthalmology. 30(2) :115-9, 2002 Apr.

Saum SL. Thomas E. Lewis AM. Croft PR. Effect of intensive therapy on the microvascular complications of type 1 diabetes melli tus. JAMA. 287(19):2563-9, 2002 May 15.

Livingston PM, Carson CA, Stanislavsky YL, Lee SE, Guest CS, Taylor HR. Methods for a population-based study: The Melbourne Vi sual Impairment Project. Ophthalmol Epidemiol 1994;1:139-148.

Livingston PM, Guest CS, Bateman A, Woodcock N, Taylor HR. Cost effectiveness of recruitment methods in a population based epi demiological study. Aust J Pub Health 1994;18:314-318.

Livingston PM, Guest CS, Stanislavsky Y, Lee S, Bayley S, Walker C, McKean C, Taylor HR. A population based estimate of cataract prevalence: The Melbourne Visual Impairment Project Experience. Dev Ophthalmol 1994;26:1-6.

Young IM, Rait JL, Guest CS, Carson CA, Taylor HR. Comparison between Fastpac and conventional Humphrey perimetry. Aust N Z J Ophthalmol 1994;22:95-99

Livingston PM, Lee SE, De Paola C, Carson CA, Guest CS, Taylor HR. Knowledge of glaucoma and its relationship to self-care pra ctices, in a population sample. Aust N Z J Ophthalmol 1995;23:37-41.

Young IM, Rait JL, Carson CA, Taylor HR. Fastpac visual field screening. Ophthalmic Epidemiol 1995;2:117-121.

McCarty CA, Lee SE, Livingston PM, Bissinella M, Taylor HR. Ocular exposure to UV-B in sunlight: the Melbourne Visual Impairme nt Project Model. WHO Bulletin 1996;74:353-360.

Carson CA, Keeffe JE, Livingston PM, Taylor HR. The importance and state of medical and public health research related to visi on in Australia. Aust N Z J Ophthalmol 1996;24:3-5.

Taylor HR, McCarty CA. Ozone depletion: the ocular effects of UV-B exposure. Cancer Forum 1997;20:223-225.

McCarty CA, Lee SE, Livingston PM, Taylor HR. Assessment of lifetime ocular exposure to UV-B: the Melbourne Visual Impairment Project Model. Dev Ophthalmol 1996;27:9-13.

Taylor HR, Livingston PM, Stanislavsky YL, McCarty CA. Visual impairment in Australia: Distance and near visual acuity and vis ual field findings of the Melbourne Visual Impairment Project. Am J Ophthalmol 1997;123:328-337.

McCarty CA, De Paola C, Livingston PM, Taylor HR. Reliability of a food frequency questionaire to assess dietary antioxidant i ntake. Ophthalmic Epidemiol 1997;4:33-39.

McCarty CA, Taylor HR. Protecting eyes from sun damage. Med J Aust 1997;166:671

Livingston PM, Lee SE, McCarty CA, Taylor HR. A comparison of participants with non-participants in a population- based epidem iologic study: the Melbourne visual impairment project. Ophthalmic Epidemiol 1997;4:73-82.

Livingston PM, McCarty CA, Taylor HR. Visual impairment and socio-economic factors. Br J Ophthalmol 1997;81:574-577.

Wensor MD, McCarty CA, Stanislavsky YL, Livingston PM, Taylor HR. The prevalence of glaucoma in the Melbourne Visual Impairmen t Project. Ophthalmol 1998;105:733-739.

McCarty CA, Lloyd-Smith CW, Lee SE, Stanislavsky YL, Livingston PM, Taylor HR. Use of eye care services by people with diabete s: the Melbourne visual impairment project. Br J Ophthalmol 1998;82:410-414.

McCarty CA, Bansal AK, Livingston PM, Stanislavsky YL, Taylor HR. The epidemiology of dry eye in Melbourne, Australia. Oph thalmol 1998;105:1114-1119

Weih LM, Van Newkirk M, McCarty CA, Taylor HR. Patterns of glaucoma medication use in urban and rural Victoria. Aust NZ J Ophthalmol 1998;S12-15

Livingston PM, McCarty CA, Taylor HR. Knowledge, attitudes and self-care practices associated with age-related eye disease in Australia. Br J Ophth 1998;82:780-785

McCarty CA, Keeffe JE, Taylor HR. The need for cataract surgery: projections based on lens opacity, visual acuity and personal concern. Br J Ophthalmol 1999;83:62-65 (also in Ophthalmol Digest 1999;6:23-24)

McCarty CA, Wood CA, Fu CL, Livingston PM, Mackersey S, Stanislavsky YL, Taylor HR. Schizophrenia, psychotropic medication and cataract. Ophthalmol 1999;106:683-687

McCarty CA, McCarty DJ, Van Newkirk MR, Taylor HR. Self-reported diabetes and distribution of HbA1C in a population-based samp le in Victoria. Med J Aust 1999;170:238-239

Wensor MD, McCarty CA, Taylor HR. The prevalence and risk factors of myopia in Victoria, Australia. Arch Ophthalmol 1999;1 17:658-663

Liou HL, McCarty CA, Jin CL, Taylor HR. Prevalence and predictors of under-corrected refractive errors in the Victorian popula tion. Am J Ophthalmol 1999;127:590-596

McCarty CA, Fu C, Taylor HR. The epidemiology of ocular trauma in Australia. Ophthalmol 1999;106:1847-1852

McCarty CA, Mukesh BN, Fu C, Taylor HR. The epidemiology of cataract in Australia. Am J Ophthalmol 1999;128:446-465

Taylor HR. Cataract surgery: How much surgery do we have to do? Br J Ophthalmol 2000;84:1-2

Weih LM, Van Newkirk MR, McCarty CA, Taylor HR. Age-specific causes of bilateral vision impairment. Arch Ophthalmol 2000;1 18:264-269

McCarty CA, Fu C, Taylor HR. The epidemiology of pterygium in Victoria, Australia. Br J Ophthalmol 2000;84:289-292

McCarty CA, Taylor HR. Pseudoexfoliation Syndrome in Australian adults. Am J Ophthalmol 2000;129:629-633

McCarty CA, Mukesh BN, Taylor HR. Operated and unoperated cataract in Australia. Clin Exp Ophthalmol 2000;28:77-82

McKay R, McCarty CA, Taylor HR. Diabetic Retinopathy in Victoria, Australia: the Visual Impairment Project. Br J Ophthalmo l 2000;84:865-870

VanNewkirk MR, Mukesh BN, Wang JJ, Mitchell P, Taylor HR, McCarty CA. The prevalence of age-related maculopathy: The Visual Im pairment Project. Ophthalmol 2000;107:1593-1600

Weih LM, McCarty CA, Taylor HR. Functional implications of vision impairment. Clin Exp Ophthalmol 2000;28:153-155

VanNewkirk MR, Weih L, McCarty CA, Stanislavsky YL, Keeffe JE, Taylor HR. Visual impairment and eye diseases in elderly instit utionalized Australians. Ophthalmol 2000;107:2203-2208

McCarty CA, Nanjan BM, Taylor HR. Attributable risk estimates for cataract to prioritise medical and public health action. Invest Ophthalmol Vis Sci 2000;41:3720-5

McKay R, McCarty CA, Taylor HR. Diabetes in Victoria, Australia: the Visual Impairment Project. Aust NZ J Publ Health 2000 ;84:865-870

Brown SA, Weih LM, Fu CL, Dimitrov P, Taylor HR, McCarty CA. Prevalence of amblyopia and associated refractive errors in an ad ult population in Victoria, Australia. Ophthalmic Epi 2000;7:249-258

VanNewkirk M, Taylor HR, Weih LM, McCarty CA. The cause-specific prevalence of bilateral visual impairment in Victoria, Austra lia. The Visual Impairment Project. Ophthalmol 2001;108:960-967

McKay R, McCarty CA, Taylor HR. Diabetic retinopathy inVictoria, Australia: the Visual Impairment Project. Focus on Diabet ic Retinopathy 2001;8:44-45

Dimitrov PN, Nanjan MB, Taylor HR, McCarty CA. Association of presbyopic correction with changes in visual fields. Clin Ex p Ophthalmol 2000;28:165-168

Taylor HR, McCarty CA, Nanjan MB. Vision impairment predicts five-year mortality. Tr Am Ophthal Soc 2000;98:91-96

McCarty CA, Nanjan MB, Taylor HR. Vision impairment predicts five-year mortality. Br J Ophthalmol 2001;85:322-326

Dimitrov PN,Mukesh BN, Taylor HR, McCarty CA. Intraocular pressure before and after cataract surgery in the Melbourne Visual I mpairment Project. Clin Exp Ophthalmol 2001;29:128-132

Brown S, Weih L, Mukesh BN, McCarty C, Taylor HR. Assessment of adult stereopsis using the Lang 1 Stereotest: A pilot study. Bin Vis Strab Q 2001;16:91-98

Weih LM, Mukesh BN, McCarty CA, Taylor HR. Association of demographic, familial, medical, and ocular factors with intraocular pressure. Arch Ophthalmol 2001;119:875-80

McCarty CA, Mukesh, BN, Fu CL, Mitchell P, Taylor HR. Risk factors for age-related maculopathy: The Visual Impairment Project. Arch Ophthalmol (In Press)

Maini R, Keeffe J, Weih L, Taylor HR. Correction of refractive error in the Victorian population -- the feasibility of \'off t he shelf\' spectacles. Br J Ophthalmol (In Press)

McCarty CA, Mukesh BN, Guymer RH, Baird PN, Taylor HR. Cholesterol lowering medications reduce the risk of age- related maculo pathy progression. Med J Aust (In Press)

Scot, IU, Schein OD, Feuer WJ, Folstein MF, Bandeen-Roche K. Emotional distress in patients with retinal disease. Am J Oph thalmol. 2001;131:584-589

OTHER REFERENCES

Gandorfer A. Ulbig MW. [Diabetic retinopathy. Only early therapy prevents blindness]. [German] MMW Fortschritte der Medizin. 144(26):37-40, 2002 Jun 27.

Kurtenbach A. Flogel W. Erb C. Anomaloscope matches in patients with diabetes mellitus. Graefes Archive for Clinical & Experimental Ophthalmology. 240(2):79-84, 2002 Feb.

Shiragami C. Shiraga F. Matsuo T. Tsuchida Y. Ohtsuki H. Risk factors for diabetic choroidopathy in patients with diabetic retinopathy. Graefes Archive for Clinical & Experimental Ophthalmology. 240(6):436-42, 2002 Jun.

Attebo K, Mitchell P, Smith W. Visual acuity and the causes of visual loss in Australia: the Blue Mountains Eye Study. Oph thalmol 1996;103:357-364

Smith W, Mitchell P, Seeder SR. Smoking and age-related maculopathy. Arch Ophthalmol 1996;114:1518-1523

Klein BEK, Klein R, Lee KE, Cruickshanks KJ. Performance-based and self-assessed measures of visual function as related to his tory of falls, hip fractures, and measured gait time. The Beaver Dam Eye Study. Ophthalmol 1998;105:160-164

Ivers RQ, Cumming RG, Mitchell P, Attebo K. Visual impairment and falls in older adults: The Blue Mountains Eye Study. J A m Geriatr Soc 1998;46:58-64

Rovner BW, Ganguli M. Depression and disability associated with impaired vision: the MoVies Project. J Am Geriatr Soc.1998 ;46:617-9

Wright SE, Keeffe JE, Thies LS. Direct costs of blindness in Australia. Clin Experiment Ophthalmol. 2000;28:140-2

Useful Links

Important information can be found on the websites of associated organsiations.

Useful Links for Health Professionals

More Info for Health Professionals

What is Diabetes

What is diabetic retinopathy?

Retinopathy Chart

Relevant Eye Care Journal Articles

Professional Journals of Interest

Medicare and Optometry

Royal Victorian Institute for the Blind - Free Publications List

Royal Victorian Institute For the Blind - Services Booklet

Vision Australia

RVIB - Working with People who have Vision Loss

NHMRC Guidelines for Diabetic Retinopathy

ICEE - International Centre for Eyecare Education

ICEE Media Release

Redfern Aboriginal Eye Care Clinic

RVEEH Retinopathy Poster

Lions Eye Health Program - Australia resource materials

Australian Lions Working with the Vietnamese Community

Eye and Ear Hospital Services

Australian Lions working with the Turkish Community

Diabetic retinopathy diagnosis and managment

Australian Optometrists detect Diabetic Retinopathy

Latest titles in Ophthahlamology

National accredited Training Program - Screening for Diabetic Retinopathy

Diabetic Maculopathy

Screening for Diabetic Retinopathy: A Planning & Resource Guide

Search

Subscribe

Enter your email address below to be kept up to date with the latest from the Eyes on Diabetes Forum

Web Development by SitePoint.com.au

Level Triple-A conformance icon, W3C-WAI Web Content Accessibility Guidelines 1.0 CSS conformance icon. This Site uses valid CSS! XHTML 1.0 conformance icon. This Site uses valid XHTML 1.0!